Blue light-filtering IOL significantly reduces driving glare disability

Article

Using blue light-filtering IOLs, as opposed to UV-only filtering non-toric IOLs, produces a significantly greater reduction in glare disability when driving.

Using blue light-filtering IOLs, as opposed to UV-only filtering non-toric IOLs, produces a significantly greater reduction in glare disability when driving, reveals an investigation in the Journal of Cataract and Refractive Surgery.

Dr Rob Gray and his team, Department of Applied Psychology, Arizona State University, Mesa, Arizona, USA, conducted a comparative case series on patients wearing a blue light-filtering IOL (the test IOL) or an ultraviolet (UV)-only filtering non-toric IOL (the control IOL).

Patients were asked to perform left-turn manoeuvres in a driving simulator while wearing best spherocylindrical correction. Time to collision minus the time taken to turn at a junction into oncoming traffic was used to define the safety margin. The same process was repeated but during daytime driving conditions with a glare source.

The test IOL was administered to 18 patients and the control IOL was given to 15 patients. Safety margins were significantly greater in patients with the test IOL in situations where glare was present.

Patients with the test IOL presented with a significantly lower glare susceptibility than the control patients. The blue light-filtering IOL enabled drivers to turn left in situations where glare is present.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.